How is hereditary hemochromatosis diagnosed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnosis of Hereditary Hemochromatosis

Diagnose hereditary hemochromatosis by first measuring fasting transferrin saturation (TSAT) and serum ferritin, then confirm with HFE genetic testing in patients with elevated iron indices, and finally assess for iron overload and organ damage using MRI or liver biopsy when indicated. 1

Initial Screening: Serum Iron Studies

The diagnostic pathway begins with measuring serum iron parameters in patients with clinical suspicion (unexplained liver disease, diabetes, arthropathy, fatigue, or family history):

  • Transferrin saturation (TSAT): The diagnostic hallmark of hemochromatosis 2

    • TSAT >45% in females or >50% in males/post-menopausal women suggests iron overload 1
    • This reflects the expanded circulating iron pool characteristic of hemochromatosis
  • Serum ferritin:

    • 200 µg/L in females or >300 µg/L in males/post-menopausal women indicates provisional iron overload 1

    • Ferritin >1,000 ng/mL at diagnosis identifies patients at higher risk for advanced hepatic fibrosis 3

Critical caveat: Elevated ferritin is common and reflects hemochromatosis in only a minority of cases 2. Ferritin can be elevated in nonalcoholic fatty liver disease, alcoholic liver disease, and inflammatory conditions—all more common than hemochromatosis 3. Always exclude secondary causes before proceeding.

Genetic Testing: Confirming the Diagnosis

Once iron studies suggest overload, proceed to HFE genetic testing:

For HFE-Related Hemochromatosis (85-90% of cases)

In patients homozygous for p.Cys282Tyr (C282Y/C282Y) with elevated TSAT and ferritin as defined above, the diagnosis of hemochromatosis is confirmed without requiring liver biopsy or MRI 1. This represents the most straightforward diagnostic scenario.

  • C282Y/H63D compound heterozygotes may also develop iron overload but with lower penetrance 4
  • Approximately 70% of C282Y homozygotes develop phenotypic expression, and fewer than 10% develop severe disease 4

For Non-HFE Genotypes

If iron studies show overload but genetic testing reveals other HFE genotypes (or no HFE mutations), diagnosis requires demonstrating hepatic iron overload on MRI or liver biopsy 1. This is essential because:

  • Non-HFE hemochromatosis (mutations in HJV, HAMP, TfR2, SLC40A1) accounts for 10-15% of hereditary cases 4
  • These forms are rare but highly penetrant, potentially causing severe early complications 2
  • Secondary causes of iron overload must be excluded (see classification in guidelines 4)

Assessing Iron Overload and Organ Damage

After confirming the genetic diagnosis, quantify iron burden and evaluate for complications:

Hepatic Iron Assessment

  • MRI T2*: Non-invasive quantification of hepatic iron deposition, now preferred over biopsy in most patients 3
  • Liver biopsy: Reserved for patients where:
    • Ferritin >1,000 ng/mL (higher risk of advanced fibrosis) 3
    • Uncertainty about degree of fibrosis exists
    • Non-HFE hemochromatosis requires confirmation of iron deposition 1

Staging for Complications

The stage of liver fibrosis and end-organ damage must be carefully assessed at diagnosis because they determine disease management 1:

  • Liver fibrosis assessment: Use non-invasive methods (elastography) or biopsy if ferritin >1,000 ng/mL
  • Hepatocellular carcinoma screening: Patients with advanced fibrosis/cirrhosis require lifelong HCC surveillance 1
  • Evaluate other organs: Screen for diabetes, cardiac dysfunction, hypogonadism, arthropathy, and skin changes 1

Diagnostic Algorithm Summary

  1. Measure fasting TSAT and ferritin in patients with clinical suspicion
  2. If elevated (TSAT >45-50%, ferritin >200-300 µg/L): Order HFE genetic testing
  3. If C282Y homozygous with elevated iron indices: Diagnosis confirmed 1
  4. If other/no HFE mutations with elevated iron indices: Obtain MRI or liver biopsy to confirm hepatic iron overload 1
  5. Assess for complications: Evaluate liver fibrosis (especially if ferritin >1,000 ng/mL), screen for end-organ damage 1, 3
  6. Exclude secondary causes: Rule out alcoholic liver disease, NAFLD, chronic hemolytic anemia, transfusional overload 3

Important Pitfalls to Avoid

  • Do not diagnose hemochromatosis based on C282Y homozygosity alone—phenotypic expression (elevated iron indices) is required, as penetrance is incomplete 4
  • Do not assume all elevated ferritin is hemochromatosis—inflammatory conditions and liver disease are far more common causes 3, 2
  • Do not skip genetic testing—it differentiates hereditary from secondary iron overload and guides family screening 5
  • Do not forget to screen first-degree relatives of confirmed cases with genetic testing after age 18 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.